Search   Advanced Search
LATEST NEWS
 
 
News
 Latest Headlines
 Quick Facts
 Breaking News
 Top Stories
 Feature Articles
 Politics
 US Policy
 General
 Commodities
 Canadian
 UK
 Indian
 Wallstreet Events
 US Economic News
 European Economic News
 Asian Economic News
 All Economic News
 FX Top Stories
 Currency Alerts
 Mkt Sensitive News
 Politics
 European Mkt Updates
 Asian Mkt Updates
 Treasury Mkt Updates
 Pop
 Rock
 Classic Rock
 Rap/Hip-Hop
 Country
 Alternative
 Oldies
 Movie Reviews
 DVD Releases
 Box Office
 Slide Shows
 Business News
Commentary/Analysis
 Daily Market Analysis
 US Market Updates
 US Commentary
 Asian Commentary
 European Commentary
 Canadian Commentary
 Indian Commentary
 Sector/Market Trends
Stock Alerts
 Stocks To Watch
 Long Term Stocks
 Before the Bell
 $5 and Under
 After the Bell
 Intraday Updates
 IPOs
 Hot Stocks
Earnings Calendars
 Upcoming Earnings
 Latest Earnings
 Pos Pre Announcements
 Neg Pre Announcements
Corporate Calendars
 Stock Splits
 Stock Buybacks
 Dividends
 Conference Calls
 FDA Calendar
 Board Meetings
 Mergers & Acquisitions
Ratings Changes
 Upgrades
 Downgrades
 Coverage Initiations
 Coverage Reiterated
 All Videos
 Market Commentary
 Top Stories
 Economic News
 Political News
 Foreign Markets
 Corporate News
 Entertainment News
 Top Stories
 Earnings
 Mergers & Acquisitions
 Market Commentary
 Economic News
 IPOs and New Issues
 Corporate News
 Forex News
 Interviews
 Private Equity
Economic Calendar
RTT DeskAlert
Font Down Font Up

 
Brunswick Q3 Loss Narrows - Update
10/29/2009 10:56 AM  ET

RELATED NEWS
Brunswick Q3 Loss Narrows - Quick Facts
Brunswick Corp Appoints Andrew Graves President, Brunswick Boat Group - Quick Facts
Brunswick Closed At Over 11 1/2 Month High Monday
Brunswick Corp. Has Climbed Above A Trading Range
Brunswick Launches Cash Tender Offer To Buy Up To $75 Mln Of Its 2013 Notes - Quick Facts
TOP MARKET NEWS
Stocks Close Mostly Lower Amid Disappointing Quarterly Results - U.S. Commentary
Stocks Remain Stuck In The Red In Mid-Afternoon Trading - U.S Commentary
Stocks Posting Moderate Losses In Early Afternoon Trading - U.S. Commentary
New Guidelines Recommend Women Wait Until 21 For Cervical Cancer Screening
Stocks Seeing Further Downside In Late Morning Trading - U.S. Commentary
(RTTNews) -  Marine engines, boats, fitness and sports equipment maker Brunswick Corp. (BC: News ) Thursday posted a narrower loss for the third quarter, despite revenues decline, by reducing its marine dealer pipeline and executing cost reduction program. Brunswick's adjusted loss was narrower than analysts' estimates.

Third quarter net loss narrowed 84% to $114.3 million or $1.29 per share from $729.1 million or $8.26 per share in 2008, primarily the result of marine sales that dropped 40% year-over-year. Brunswick said adjusted loss per share was $1.21 compared with $0.33 a year ago.

On average, five analysts polled by Thomson Reuters expected the company to report a loss of $1.34 per share. Analysts' estimates typically exclude special items.

Net loss per share for the third quarter of 2009 included restructuring charges of $0.32 per share and $0.24 per share benefit from special tax items.

Net sales for the quarter declined 36% to $665.8 million from $1.04 billion a year earlier. Four Wall Street analysts expected revenues of $701.13 million.

Third-quarter total Marine segment sales were 40% lower at $461.6 million compared with $766 million last year. Marine Engine segment sales were $363.5 million, down 29% from $515.2 million a year ago. International sales, representing 41% of total segment sales in the quarter, declined 27%.

Boat segment net sales were $118.2 million, down 62% from $314.2 million in 2008. International sales, representing 43% of total segment sales, decreased 60% during the period.

Fitness segment sales in the third quarter of 2009 totaled $126.8 million, down 22% from $161.6 million in the year-ago quarter. International sales, representing 55% of total
segment sales in the quarter, declined 15%.
Bowling & Billiards segment sales totaled $77.5 million, down 30% from $111.1 million last year.

Operating loss narrowed 81% to $109.4 million from $566.3 million year-over-year, the company said.

Cost of sales for the third quarter declined 32% to $590.2 million from $862.3 billion a year earlier. Restructuring, exit and impairment charges for the third quarter declined 26% to $28.8 million from $39.1 million year-on-year.

Research and development expense for the third quarter declined 38% to $19.5 million from $31.2 million in 2008.

Brunswick said cash totaled $624.1 million, up from the 2008 year-end balance of $317.5 million. Pipeline reduction and inventory management strategies led to lower dealer inventory levels and company cash flow benefits, while having a negative impact on the company's revenue and earnings.

To receive FREE breaking news email alerts for Brunswick Corp. and others in your portfolio


 1   2   Next Page 


Share Article:   Del.icio.us    Digg    Y! My Web    Facebook    My Space

Email        Print        

     
  Trading Center
 

More Breaking News-US

127  Indian Appointed To Key IMF Post
126  FDA Approves Bristol-Myers' Abilify To Treat Irritabilty In Pediatric Patients With Autistic Disorder - Update
125  EU Extends Review Deadline For Oracle's Proposed Takeover Of Sun Micro - Update
124  Pfizer's Geodon Approved As Adjunctive For Bipolar Disorder - Update
123  CF Nominees Enter Terra's Board - Update
122  Archipelago Learning Prices IPO Within Expected Range; Stock Soars - Update
121  Brown University And IBM Launch Multimillion-Dollar Supercomputer - Update
120  GLG Life Tech Starts Trading On Nasdaq; Shares Down 13.7% - Update
119  Global Defense Technology Prices IPO At $13/Share, Below Prior Estimate - Update
118  Dendreon Gets FDA Acceptance For Prostrate Cancer Drug Application - Update
117  Covidien's Pain Drug NDA Review Extended By FDA - Update
116  Inovio's Pre-clinincal Study Of Universal Flu Vaccines Reports Protective Response Against Multiple Influenza Strains; Stock Up - Update
115  Cloud Peak Energy Prices IPO At $15/shr - Update
114  Met-Pro Q3 Profit Plunges - Update
113  Boston Scientific Receives FDA's 510 (k)Clearance For WallFlex Fully Covered Esophageal Stent - Update
  

 

Copyright © 2009 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.

Feedback| Terms of Service | How To Use RTTNews.com| Advertise| Buy Content | RSS